Franklin Resources Inc. reduced its stake in Morgan Stanley (NYSE:MS) by 7.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,289,993 shares of the financial services provider’s stock after selling 194,766 shares during the period. Franklin Resources Inc. owned 0.13% of Morgan Stanley worth $120,156,000 as of its most recent SEC filing.
A number of other institutional investors also recently made changes to their positions in the business. Exane Derivatives boosted its holdings in shares of Morgan Stanley by 303.9% in the fourth quarter. Exane Derivatives now owns 1,979 shares of the financial services provider’s stock valued at $104,000 after acquiring an additional 1,489 shares during the period. Invictus RG boosted its holdings in shares of Morgan Stanley by 307.5% in the third quarter. Invictus RG now owns 2,335 shares of the financial services provider’s stock valued at $112,000 after acquiring an additional 1,762 shares during the period. Rational Advisors LLC acquired a new stake in shares of Morgan Stanley in the third quarter valued at approximately $116,000. Zions Bancorporation boosted its holdings in shares of Morgan Stanley by 176.1% in the third quarter. Zions Bancorporation now owns 2,463 shares of the financial services provider’s stock valued at $119,000 after acquiring an additional 1,571 shares during the period. Finally, First Dallas Securities Inc. acquired a new stake in shares of Morgan Stanley in the fourth quarter valued at approximately $121,000. Institutional investors own 86.07% of the company’s stock.
In other Morgan Stanley news, CFO Jonathan Pruzan sold 52,204 shares of the firm’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $55.35, for a total value of $2,889,491.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Chairman James P. Gorman sold 100,000 shares of the firm’s stock in a transaction on Thursday, February 15th. The shares were sold at an average price of $55.34, for a total value of $5,534,000.00. The disclosure for this sale can be found here. In the last three months, insiders sold 239,254 shares of company stock valued at $13,085,019. 0.24% of the stock is owned by corporate insiders.
Morgan Stanley (NYSE:MS) last released its earnings results on Thursday, January 18th. The financial services provider reported $0.84 EPS for the quarter, beating analysts’ consensus estimates of $0.77 by $0.07. Morgan Stanley had a return on equity of 10.07% and a net margin of 14.10%. The company had revenue of $9.50 billion during the quarter, compared to the consensus estimate of $9.25 billion. During the same quarter last year, the company earned $0.81 earnings per share. Morgan Stanley’s quarterly revenue was up 5.3% compared to the same quarter last year. equities research analysts expect that Morgan Stanley will post 4.51 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Thursday, February 15th. Shareholders of record on Wednesday, January 31st were issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 1.72%. The ex-dividend date of this dividend was Tuesday, January 30th. Morgan Stanley’s dividend payout ratio (DPR) is currently 32.36%.
Several research firms have recently weighed in on MS. UBS Group raised Morgan Stanley to an “overweight” rating in a report on Wednesday, January 10th. Atlantic Securities raised Morgan Stanley from a “neutral” rating to an “overweight” rating and set a $61.00 price objective for the company in a report on Wednesday, January 10th. Keefe, Bruyette & Woods raised Morgan Stanley from a “market perform” rating to an “outperform” rating and set a $59.00 price objective for the company in a report on Tuesday, December 12th. Zacks Investment Research raised Morgan Stanley from a “hold” rating to a “buy” rating and set a $59.00 price objective for the company in a report on Monday, December 11th. Finally, Societe Generale set a $61.00 price objective on Morgan Stanley and gave the company a “neutral” rating in a report on Monday, January 22nd. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Morgan Stanley currently has an average rating of “Buy” and a consensus target price of $54.07.
WARNING: This piece was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of US & international copyright legislation. The original version of this piece can be read at https://www.americanbankingnews.com/2018/03/14/morgan-stanley-ms-holdings-reduced-by-franklin-resources-inc.html.
Morgan Stanley Profile
Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.